Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative ColitisCompleted
NCT04424303N/AUpdated Jan 15, 2026
Sponsor: Pfizer
Ulcerative Colitis
France
Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)Active Not Recruiting
NCT06613984N/AUpdated Jan 14, 2026
Sponsor: Pfizer
COVID-19 Vaccination
South Korea
Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWSCompleted
NCT04697381Phase 3Updated Jan 14, 2026
Sponsor: Pfizer
Prader-Willi Syndrome
Japan
Etrasimod for Immune Checkpoint Inhibitor Diarrhea and ColitisWithdrawn
NCT06521762Phase 2Updated Jan 14, 2026
Sponsor: Yale University
Immune Checkpoint Inhibitor-Related Diarrhea and Colitis
United States
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.Completed
NCT05810038Phase 3Updated Jan 14, 2026
Sponsor: Pfizer
Migraine
China
Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy PeopleCompleted
NCT05541861Phase 1Updated Jan 13, 2026
Sponsor: BioNTech SE
SARS-CoV-2 Infection · COVID-19
United States
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult ParticipantsWithdrawn
NCT06103734Phase 3Updated Jan 13, 2026
Sponsor: Pfizer
Migraine
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminated
NCT05194072Phase 1Updated Jan 9, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Ovarian Neoplasms · Peritoneal Neoplasms · Fallopian Tube Neoplasms · Triple Negative Breast Neoplasms
United States, Canada, Germany, Spain, United Kingdom
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)Terminated
NCT04585815Phase 1, Phase 2Updated Jan 9, 2026
Sponsor: Pfizer
Carcinoma, Non-Small-Cell Lung
United States, Australia, Belgium, Taiwan
A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)Active Not Recruiting
NCT04721977Phase 2Updated Jan 9, 2026
Sponsor: Pfizer
Breast Cancer
Japan, South Korea, Taiwan
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.Completed
NCT06961331N/AUpdated Jan 9, 2026
Sponsor: Pfizer
Metastatic HER2+ Advanced Breast Cancer
United States
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During PregnancyActive Not Recruiting
NCT05198245N/AUpdated Jan 8, 2026
Sponsor: Pfizer
Migraine
United States
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese AdultsCompleted
NCT07235137Phase 1Updated Jan 7, 2026
Sponsor: Pfizer
Healthy Participant
China
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.Completed
NCT05228470Phase 2Updated Jan 6, 2026
Sponsor: Pfizer
Elranatamab · Myeloma · Multiple Myeloma · Relapsed Multiple Myeloma
China
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)Completed
NCT03885037N/AUpdated Jan 6, 2026
Sponsor: Pfizer
Rheumatoid Arthritis
Japan
ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By ElranatamabNot Yet Recruiting
NCT07320326N/AUpdated Jan 6, 2026
Sponsor: Peking University People's Hospital
TCE-RRMM
China
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AMLActive Not Recruiting
NCT05199051Phase 2Updated Jan 5, 2026
Sponsor: Centre Antoine Lacassagne
AML · Leukaemia (Acute Myeloid)
France
Besponsa Post Marketing Surveillance StudyCompleted
NCT04307134N/AUpdated Dec 31, 2025
Sponsor: Pfizer
Hematologic Malignancy
South Korea
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast CancerTerminated
NCT05553522Phase 1Updated Dec 31, 2025
Sponsor: Baptist Health South Florida
Brain Metastases · HER2-positive Breast Cancer
United States
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)Completed
NCT06072196N/AUpdated Dec 31, 2025
Sponsor: Pfizer
Prostatic Neoplasms
United States
Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCDTerminated
NCT04930445N/AUpdated Dec 31, 2025
Sponsor: Pfizer
Sickle Cell Disease
United States
A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne VulgarisCompleted
NCT06671834Phase 1Updated Dec 30, 2025
Sponsor: Pfizer
Acne Vulgaris
Canada
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryActive Not Recruiting
NCT03809000Phase 2Updated Dec 30, 2025
Sponsor: RTOG Foundation, Inc.
Prostate Cancer
United States, Canada
A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSVTerminated
NCT06102174Phase 1Updated Dec 30, 2025
Sponsor: Pfizer
Respiratory Syncytial Virus Infections
United States, Japan, South Africa
Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated PneumoniaCompleted
NCT05671328N/AUpdated Dec 26, 2025
Sponsor: University Hospital, Lille
Ventilator Associated Pneumonia · Pulmonary Aspergillosis Invasive
France

Previous page Next page